DANAHER CORP (1DHR.MI) Stock Price, Forecast & Analysis
Europe - Euronext Milan - BIT:1DHR - US2358511028 - Common Stock
1DHR.MI Key Statistics, Chart & Performance
The current stock price of 1DHR.MI is 196.08 EUR.
1DHR.MI Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| 56S1.DE | SARTORIUS STEDIM BIOTECH | 47.96 | 20.12B | ||
| DIM.PA | SARTORIUS STEDIM BIOTECH | 47.77 | 20.04B | ||
| SRT3.DE | SARTORIUS AG-VORZUG | 53.84 | 18.38B | ||
| SRT.DE | SARTORIUS AG | 41.54 | 14.18B | ||
| QIA.DE | QIAGEN N.V. | 19.4 | 8.45B | ||
| 1SXP.DE | SCHOTT PHARMA AG& CO KGAA | 15.36 | 2.24B | ||
| EVT.DE | EVOTEC SE | N/A | 1.91B | ||
| GXI.DE | GERRESHEIMER AG | 7.29 | 929.13M | ||
| FF.MI | FINE FOODS & PHARMACEUTICALS | 10.76 | 211.33M | ||
| ALECR.PA | EUROFINS CEREP-REGR | 24.9 | 178.00M | ||
| MLC.I | MALIN CORP PLC | N/A | 33.34M |
Related stock screener links
About 1DHR.MI
Company Profile
Danaher Corp. engages in the design, manufacture, and marketing of professional, medical, industrial, and commercial products and services. The company is headquartered in Washington, Washington Dc and currently employs 61,000 full-time employees. The firm operates through three segments: Biotechnology, Life Sciences and Diagnostics. The Biotechnology segment includes the bioprocessing and discovery and medical businesses and offers a broad range of equipment, consumables and services that are primarily used by customers to advance and accelerate the research, development, manufacture and delivery of biological medicines. The Life Sciences segment offers a broad range of instruments, consumables, services and software that are primarily used by customers to study the basic building blocks of life, including deoxyribonucleic acid (DNA) and ribonucleic acid (RNA), nucleic acid, proteins, metabolites and cells. The Diagnostics segment offers clinical instruments, consumables, software and services that hospitals, physicians’ offices, reference laboratories and other critical care settings use to diagnose disease and make treatment decisions.
Company Info
DANAHER CORP
2200 Pennsylvania Ave NW Ste 800W
WASHINGTON WASHINGTON DC US
Employees: 61000
Phone: 12028280850
DANAHER CORP / 1DHR.MI FAQ
What does DANAHER CORP do?
Danaher Corp. engages in the design, manufacture, and marketing of professional, medical, industrial, and commercial products and services. The company is headquartered in Washington, Washington Dc and currently employs 61,000 full-time employees. The firm operates through three segments: Biotechnology, Life Sciences and Diagnostics. The Biotechnology segment includes the bioprocessing and discovery and medical businesses and offers a broad range of equipment, consumables and services that are primarily used by customers to advance and accelerate the research, development, manufacture and delivery of biological medicines. The Life Sciences segment offers a broad range of instruments, consumables, services and software that are primarily used by customers to study the basic building blocks of life, including deoxyribonucleic acid (DNA) and ribonucleic acid (RNA), nucleic acid, proteins, metabolites and cells. The Diagnostics segment offers clinical instruments, consumables, software and services that hospitals, physicians’ offices, reference laboratories and other critical care settings use to diagnose disease and make treatment decisions.
What is the stock price of DANAHER CORP today?
The current stock price of 1DHR.MI is 196.08 EUR. The price increased by 0.97% in the last trading session.
Does 1DHR stock pay dividends?
DANAHER CORP (1DHR.MI) has a dividend yield of 0.57%. The yearly dividend amount is currently 0.9.
How is the ChartMill rating for DANAHER CORP?
1DHR.MI has a ChartMill Technical rating of 3 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
What is the employee count for 1DHR stock?
DANAHER CORP (1DHR.MI) currently has 61000 employees.
What is the market capitalization of 1DHR stock?
DANAHER CORP (1DHR.MI) has a market capitalization of 138.50B EUR. This makes 1DHR.MI a Large Cap stock.
What is the next earnings date for 1DHR stock?
DANAHER CORP (1DHR.MI) will report earnings on 2026-01-27, after the market close.
1DHR.MI Technical Analysis
ChartMill assigns a technical rating of 3 / 10 to 1DHR.MI.
1DHR.MI Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to 1DHR.MI. 1DHR.MI has an excellent financial health rating, but there are some minor concerns on its profitability.
1DHR.MI Financial Highlights
Over the last trailing twelve months 1DHR.MI reported a non-GAAP Earnings per Share(EPS) of 6.58. The EPS increased by 3.63% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 14.43% | ||
| ROA | 4.38% | ||
| ROE | 6.86% | ||
| Debt/Equity | 0.33 |
1DHR.MI Forecast & Estimates
29 analysts have analysed 1DHR.MI and the average price target is 223.81 EUR. This implies a price increase of 14.14% is expected in the next year compared to the current price of 196.08.
For the next year, analysts expect an EPS growth of 4.05% and a revenue growth 3.11% for 1DHR.MI